¿Ã·¹Æ÷Æ® : ´ëÇз¹Æ÷Æ®, Á·º¸, ½ÇÇè°úÁ¦, ½Ç½ÀÀÏÁö, ±â¾÷ºÐ¼®, »ç¾÷°èȹ¼­, Çо÷°èȹ¼­, ÀÚ±â¼Ò°³¼­, ¸éÁ¢, ¹æ¼ÛÅë½Å´ëÇÐ, ½ÃÇè ÀÚ·á½Ç
¿Ã·¹Æ÷Æ® : ´ëÇз¹Æ÷Æ®, Á·º¸, ½ÇÇè°úÁ¦, ½Ç½ÀÀÏÁö, ±â¾÷ºÐ¼®, »ç¾÷°èȹ¼­, Çо÷°èȹ¼­, ÀÚ±â¼Ò°³¼­, ¸éÁ¢, ¹æ¼ÛÅë½Å´ëÇÐ, ½ÃÇè ÀÚ·á½Ç
·Î±×ÀΠ ȸ¿ø°¡ÀÔ

ÆÄÆ®³Ê½º

ÀÚ·áµî·Ï
 

Àå¹Ù±¸´Ï

´Ù½Ã¹Þ±â

ÄÚÀÎÃæÀü

¢¸
  • Merck, the FDA, and the Vioxx Recall   (1 ÆäÀÌÁö)
    1

  • Merck, the FDA, and the Vioxx Recall   (2 ÆäÀÌÁö)
    2

  • Merck, the FDA, and the Vioxx Recall   (3 ÆäÀÌÁö)
    3

  • Merck, the FDA, and the Vioxx Recall   (4 ÆäÀÌÁö)
    4

  • Merck, the FDA, and the Vioxx Recall   (5 ÆäÀÌÁö)
    5

  • Merck, the FDA, and the Vioxx Recall   (6 ÆäÀÌÁö)
    6

  • Merck, the FDA, and the Vioxx Recall   (7 ÆäÀÌÁö)
    7

  • Merck, the FDA, and the Vioxx Recall   (8 ÆäÀÌÁö)
    8

  • Merck, the FDA, and the Vioxx Recall   (9 ÆäÀÌÁö)
    9

  • Merck, the FDA, and the Vioxx Recall   (10 ÆäÀÌÁö)
    10

  • Merck, the FDA, and the Vioxx Recall   (11 ÆäÀÌÁö)
    11

  • Merck, the FDA, and the Vioxx Recall   (12 ÆäÀÌÁö)
    12

  • Merck, the FDA, and the Vioxx Recall   (13 ÆäÀÌÁö)
    13

  • Merck, the FDA, and the Vioxx Recall   (14 ÆäÀÌÁö)
    14

  • Merck, the FDA, and the Vioxx Recall   (15 ÆäÀÌÁö)
    15

  • º» ¹®¼­ÀÇ
    ¹Ì¸®º¸±â´Â
    15 Pg ±îÁö¸¸
    °¡´ÉÇÕ´Ï´Ù.
¢º
Ŭ¸¯ : Å©°Ôº¸±â
  • Merck, the FDA, and the Vioxx Recall   (1 ÆäÀÌÁö)
    1

  • Merck, the FDA, and the Vioxx Recall   (2 ÆäÀÌÁö)
    2

  • Merck, the FDA, and the Vioxx Recall   (3 ÆäÀÌÁö)
    3

  • Merck, the FDA, and the Vioxx Recall   (4 ÆäÀÌÁö)
    4

  • Merck, the FDA, and the Vioxx Recall   (5 ÆäÀÌÁö)
    5

  • Merck, the FDA, and the Vioxx Recall   (6 ÆäÀÌÁö)
    6

  • Merck, the FDA, and the Vioxx Recall   (7 ÆäÀÌÁö)
    7

  • Merck, the FDA, and the Vioxx Recall   (8 ÆäÀÌÁö)
    8

  • Merck, the FDA, and the Vioxx Recall   (9 ÆäÀÌÁö)
    9

  • Merck, the FDA, and the Vioxx Recall   (10 ÆäÀÌÁö)
    10



  • º» ¹®¼­ÀÇ
    (Å« À̹ÌÁö)
    ¹Ì¸®º¸±â´Â
    10 Page ±îÁö¸¸
    °¡´ÉÇÕ´Ï´Ù.
  ´õºíŬ¸¯ : ´Ý±â
X ´Ý±â
Á¿ìÀ̵¿ : µå·¡±×

Merck, the FDA, and the Vioxx Recall

ÀÎ ¼â
¹Ù·Î°¡±â
Áñ°Üã±â Űº¸µå¸¦ ´­·¯ÁÖ¼¼¿ä
( Ctrl + D )
¸µÅ©º¹»ç ¸µÅ©ÁÖ¼Ò°¡ º¹»ç µÇ¾ú½À´Ï´Ù.
¿øÇÏ´Â °÷¿¡ ºÙÇô³Ö±â Çϼ¼¿ä
( Ctrl + V )
¿ÜºÎ°øÀ¯
ÆÄÀÏ  Merck, the FDA, and the Vioxx Recall.pptx   [Size : 2 Mbyte ]
ºÐ·®   36 Page
°¡°Ý  3,000 ¿ø


īƮ
´Ù¿î¹Þ±â
īī¿À ID·Î
´Ù¿î ¹Þ±â
±¸±Û ID·Î
´Ù¿î ¹Þ±â
ÆäÀ̽ººÏ ID·Î
´Ù¿î ¹Þ±â
µÚ·Î

º»¹®/³»¿ë
_SLIDE_1_
Merck, the FDA, and the Vioxx Recall
_SLIDE_2_
Introduction of Merck
In 2005 the company ranked fourth in sales, after Pfizer, Johnson & Johnson, and GlaxoSmithKline.
In assets and market value, it ranked fifth. However, Merck ranked first in profits, earning $7.33 billion on $30.78 billion in sales.
Company
Sales ($bil)
Profits ($bil)
Assets ($bil)
Market value($bil)
Pfizer
40.36
6.20
120.06
285.27
Johnson & Johnson
40.01
6.74
46.66
160.96
GlaxosmithKline
34.16
6.34
29.19
124.79
Merck
30.78
7.33
42.59
108.76
_SLIDE_3_
1851
Dr. Ernst Christian Friedrich Schering begins developing and selling pharmaceutical products in Berlin. Three years later, the company opened its first production facility.
1891
Merck&Co. opens its doors in United S¡¦(»ý·«)



📝 Regist Info
I D : rain********
Date : 2015-12-02
FileNo : 15127080

Cart